BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30219591)

  • 1. Antipsychotic and benzodiazepine use and brain morphology in schizophrenia and affective psychoses - Systematic reviews and birth cohort study.
    Huhtaniska S; Korkala I; Heikka T; Björnholm L; Lehtiniemi H; Hulkko AP; Moilanen J; Tohka J; Manjón J; Coupé P; Kiviniemi V; Isohanni M; Koponen H; Murray GK; Miettunen J; Jääskeläinen E
    Psychiatry Res Neuroimaging; 2018 Nov; 281():43-52. PubMed ID: 30219591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term antipsychotic and benzodiazepine use and brain volume changes in schizophrenia: The Northern Finland Birth Cohort 1966 study.
    Huhtaniska S; Jääskeläinen E; Heikka T; Moilanen JS; Lehtiniemi H; Tohka J; Manjón JV; Coupé P; Björnholm L; Koponen H; Veijola J; Isohanni M; Kiviniemi V; Murray GK; Miettunen J
    Psychiatry Res Neuroimaging; 2017 Aug; 266():73-82. PubMed ID: 28618327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lifetime use of psychiatric medications and cognition at 43years of age in schizophrenia in the Northern Finland Birth Cohort 1966.
    Hulkko AP; Murray GK; Moilanen J; Haapea M; Rannikko I; Jones PB; Barnett JH; Huhtaniska S; Isohanni MK; Koponen H; Jääskeläinen E; Miettunen J
    Eur Psychiatry; 2017 Sep; 45():50-58. PubMed ID: 28728095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain morphometry of individuals with schizophrenia with and without antipsychotic medication – The Northern Finland Birth Cohort 1966 Study.
    Moilanen J; Huhtaniska S; Haapea M; Jääskeläinen E; Veijola J; Isohanni M; Koponen H; Miettunen J
    Eur Psychiatry; 2015 Jul; 30(5):598-605. PubMed ID: 25791180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.
    Ho BC; Andreasen NC; Ziebell S; Pierson R; Magnotta V
    Arch Gen Psychiatry; 2011 Feb; 68(2):128-37. PubMed ID: 21300943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain volume changes after withdrawal of atypical antipsychotics in patients with first-episode schizophrenia.
    Boonstra G; van Haren NE; Schnack HG; Cahn W; Burger H; Boersma M; de Kroon B; Grobbee DE; Hulshoff Pol HE; Kahn RS
    J Clin Psychopharmacol; 2011 Apr; 31(2):146-53. PubMed ID: 21346618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial and subcortical volumes in adolescents with early-onset psychosis: A multisite mega-analysis from the ENIGMA consortium.
    Gurholt TP; Lonning V; Nerland S; Jørgensen KN; Haukvik UK; Alloza C; Arango C; Barth C; Bearden CE; Berk M; Bohman H; Dandash O; Díaz-Caneja CM; Edbom CT; van Erp TGM; Fett AJ; Frangou S; Goldstein BI; Grigorian A; Jahanshad N; James AC; Janssen J; Johannessen C; Karlsgodt KH; Kempton MJ; Kochunov P; Krabbendam L; Kyriakopoulos M; Lundberg M; MacIntosh BJ; Rund BR; Smelror RE; Sultan A; Tamnes CK; Thomopoulos SI; Vajdi A; Wedervang-Resell K; Myhre AM; Andreassen OA; Thompson PM; Agartz I;
    Hum Brain Mapp; 2022 Jan; 43(1):373-384. PubMed ID: 33017498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of psychiatric medications in schizophrenia and other psychoses in a general population sample.
    Nykänen S; Puska V; Tolonen JP; Salo H; Isohanni M; Koponen H; Pirkola S; Penttilä M; Haapea M; Moilanen J; Miettunen J; Jääskeläinen E
    Psychiatry Res; 2016 Jan; 235():160-8. PubMed ID: 26652841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.
    Squires RF; Saederup E
    Neurochem Res; 1991 Oct; 16(10):1099-111. PubMed ID: 1686635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepines for schizophrenia.
    Volz A; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2007 Jan; (1):CD006391. PubMed ID: 17253592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grey matter abnormalities in first-episode schizophrenia and affective psychosis.
    Morgan KD; Dazzan P; Orr KG; Hutchinson G; Chitnis X; Suckling J; Lythgoe D; Pollock SJ; Rossell S; Shapleske J; Fearon P; Morgan C; David A; McGuire PK; Jones PB; Leff J; Murray RM
    Br J Psychiatry Suppl; 2007 Dec; 51():s111-6. PubMed ID: 18055926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication.
    Veijola J; Guo JY; Moilanen JS; Jääskeläinen E; Miettunen J; Kyllönen M; Haapea M; Huhtaniska S; Alaräisänen A; Mäki P; Kiviniemi V; Nikkinen J; Starck T; Remes JJ; Tanskanen P; Tervonen O; Wink AM; Kehagia A; Suckling J; Kobayashi H; Barnett JH; Barnes A; Koponen HJ; Jones PB; Isohanni M; Murray GK
    PLoS One; 2014; 9(7):e101689. PubMed ID: 25036617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality and its determinants in people with psychotic disorder.
    Suvisaari J; Partti K; Perälä J; Viertiö S; Saarni SE; Lönnqvist J; Saarni SI; Härkänen T
    Psychosom Med; 2013 Jan; 75(1):60-7. PubMed ID: 23257931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hippocampus and amygdala volumes in schizophrenia and other psychoses in the Northern Finland 1966 birth cohort.
    Tanskanen P; Veijola JM; Piippo UK; Haapea M; Miettunen JA; Pyhtinen J; Bullmore ET; Jones PB; Isohanni MK
    Schizophr Res; 2005 Jun; 75(2-3):283-94. PubMed ID: 15885519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia.
    Nesvåg R; Frigessi A; Jönsson EG; Agartz I
    Schizophr Res; 2007 Feb; 90(1-3):52-61. PubMed ID: 17218084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic drug effects on brain morphology in first-episode psychosis.
    Lieberman JA; Tollefson GD; Charles C; Zipursky R; Sharma T; Kahn RS; Keefe RS; Green AI; Gur RE; McEvoy J; Perkins D; Hamer RM; Gu H; Tohen M;
    Arch Gen Psychiatry; 2005 Apr; 62(4):361-70. PubMed ID: 15809403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study.
    Nakamura M; Salisbury DF; Hirayasu Y; Bouix S; Pohl KM; Yoshida T; Koo MS; Shenton ME; McCarley RW
    Biol Psychiatry; 2007 Oct; 62(7):773-83. PubMed ID: 17586477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies.
    Fusar-Poli P; Smieskova R; Kempton MJ; Ho BC; Andreasen NC; Borgwardt S
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1680-91. PubMed ID: 23769814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between brain morphology and outcome in schizophrenia in a general population sample.
    Jääskeläinen E; Juola P; Kurtti J; Haapea M; Kyllönen M; Miettunen J; Tanskanen P; Murray GK; Huhtaniska S; Barnes A; Veijola J; Isohanni M
    Eur Psychiatry; 2014 Sep; 29(7):456-62. PubMed ID: 24342739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.